300485.SZ
赛升药业
SZSE · Healthcare · C 制造业 · CN
CNY 9.05
−8.68%Margins
Gross margin
66.5%
EBITDA margin
14.8%
EBIT margin
-7.8%
Net margin
-5.2%
FCF margin
-17.9%
-0.6%
Return on equity
-0.6%
Return on assets
-0.9%
Return on invested capital
0.11x
Asset turnover
CNY 27.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026